Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Lipoprotein(a) and Cardiovascular Disease
Pia R. Kamstrup
Clinical Chemistry (2020) Vol. 67, Iss. 1, pp. 154-166
Open Access | Times Cited: 177

Showing 1-25 of 177 citing articles:

2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension
Giuseppe Mancia, Reinhold Kreutz, Mattias Brunström, et al.
Journal of Hypertension (2023) Vol. 41, Iss. 12, pp. 1874-2071
Open Access | Times Cited: 1600
Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement
Florian Kronenberg, Samia Mora, Erik S.G. Stroes, et al.
European Heart Journal (2022) Vol. 43, Iss. 39, pp. 3925-3946
Open Access | Times Cited: 687
Lipoprotein(a): A Genetically Determined, Causal, and Prevalent Risk Factor for Atherosclerotic Cardiovascular Disease: A Scientific Statement From the American Heart Association
Gissette Reyes‐Soffer, Henry N. Ginsberg, Lars Berglund, et al.
Arteriosclerosis Thrombosis and Vascular Biology (2021) Vol. 42, Iss. 1
Open Access | Times Cited: 475
A Modern Approach to Dyslipidemia
Amanda J. Berberich, Robert A. Hegele
Endocrine Reviews (2021) Vol. 43, Iss. 4, pp. 611-653
Open Access | Times Cited: 291
Regulation of cholesterol homeostasis in health and diseases: from mechanisms to targeted therapeutics
Yajun Duan, Ke Gong, Suowen Xu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 249
Lipoprotein(a) and its Significance in Cardiovascular Disease
Freddy Duarte Lau, Robert P. Giugliano
JAMA Cardiology (2022) Vol. 7, Iss. 7, pp. 760-760
Closed Access | Times Cited: 199
Lipoprotein(a) measurement issues: Are we making a mountain out of a molehill?
Florian Kronenberg
Atherosclerosis (2022) Vol. 349, pp. 123-135
Open Access | Times Cited: 88
Anabolic–androgenic steroids: How do they work and what are the risks?
Peter Bond, Diederik L. Smit, Willem de Ronde
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 86
Lipoprotein(a) and cardiovascular and valvular diseases: A genetic epidemiological perspective
Benoît J. Arsenault, Pia R. Kamstrup
Atherosclerosis (2022) Vol. 349, pp. 7-16
Closed Access | Times Cited: 83
Lipoprotein(a) is linked to atherothrombosis and aortic valve stenosis independent of C-reactive protein
P. E. Thomas, Signe Vedel‐Krogh, Pia R. Kamstrup, et al.
European Heart Journal (2023) Vol. 44, Iss. 16, pp. 1449-1460
Open Access | Times Cited: 44
Sex differences of lipoprotein(a) levels and associated risk of morbidity and mortality by age: The Copenhagen General Population Study
Sofie Bay Simony, Martin Bødtker Mortensen, Anne Langsted, et al.
Atherosclerosis (2022) Vol. 355, pp. 76-82
Open Access | Times Cited: 68
Three months of combination therapy with nano‐curcumin reduces the inflammation and lipoprotein (a) in type 2 diabetic patients with mild to moderate coronary artery disease: Evidence of a randomized, double‐blinded, placebo‐controlled clinical trial
Mostafa Dastani, Hamid Reza Rahimi, Vahid Reza Askari, et al.
BioFactors (2022) Vol. 49, Iss. 1, pp. 108-118
Closed Access | Times Cited: 53
Lipoprotein(a) as a Risk Factor for Cardiovascular Diseases: Pathophysiology and Treatment Perspectives
Pierandrea Vinci, Filippo Giorgio Di Girolamo, Emiliano Panizon, et al.
International Journal of Environmental Research and Public Health (2023) Vol. 20, Iss. 18, pp. 6721-6721
Open Access | Times Cited: 42
Lipoprotein(a) and Risks of Peripheral Artery Disease, Abdominal Aortic Aneurysm, and Major Adverse Limb Events
P. E. Thomas, Signe Vedel‐Krogh, Sune F. Nielsen, et al.
Journal of the American College of Cardiology (2023) Vol. 82, Iss. 24, pp. 2265-2276
Open Access | Times Cited: 25
Identification of plasma proteomic markers underlying polygenic risk of type 2 diabetes and related comorbidities
Douglas P. Loesch, Manik Garg, Dorota Matelska, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Functional interrogation of cellular Lp(a) uptake by genome-scale CRISPR screening
Taslima Khan, Juliana Bragazzi Cunha, Chinmay Raut, et al.
Atherosclerosis (2025), pp. 119174-119174
Open Access | Times Cited: 1
Equivalent Impact of Elevated Lipoprotein(a) and Familial Hypercholesterolemia in Patients With Atherosclerotic Cardiovascular Disease
Berit Storgaard Hedegaard, Christian Sørensen Bork, Morten Kaltoft, et al.
Journal of the American College of Cardiology (2022) Vol. 80, Iss. 21, pp. 1998-2010
Open Access | Times Cited: 33
Association between lipoprotein(a), fibrinogen and their combination with all-cause, cardiovascular disease and cancer-related mortality: findings from the NHANES
Zhenwei Wang, Xue-jiao Yan, Lijuan Fang, et al.
BMC Public Health (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 8
Risk factors for carotid plaque formation in type 2 diabetes mellitus
Jin Chen, Wenwen Li, Jingzhu Cao, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 7
Prediction of atrial fibrillation and stroke using machine learning models in UK Biobank
Areti Papadopoulou, Daniel Harding, Greg Slabaugh, et al.
Heliyon (2024) Vol. 10, Iss. 7, pp. e28034-e28034
Open Access | Times Cited: 7
Lipoprotein(a) Levels in Disaggregated Racial and Ethnic Subgroups Across Atherosclerotic Cardiovascular Disease Risk Levels
Ramzi Dudum, Qiwen Huang, Xiaowei Yan, et al.
JACC Advances (2024) Vol. 3, Iss. 6, pp. 100940-100940
Open Access | Times Cited: 7
Lipoprotein (a)-Related Inflammatory Imbalance: A Novel Horizon for the Development of Atherosclerosis
Ting Qin, Tianyi Ma, Kang Huang, et al.
Current Atherosclerosis Reports (2024) Vol. 26, Iss. 8, pp. 383-394
Open Access | Times Cited: 7
Association between Lipoprotein(a) and premature atherosclerotic cardiovascular disease: a systematic review and meta-analysis
Xu Tian, Nan Zhang, Gary Tse, et al.
European Heart Journal Open (2024) Vol. 4, Iss. 3
Open Access | Times Cited: 6
Therapy for Hyperlipidemia
Jennifer Wright, Savitha Subramanian
Medical Clinics of North America (2024) Vol. 108, Iss. 5, pp. 881-894
Closed Access | Times Cited: 6
Lipoprotein(a) Levels at Birth and in Early Childhood: The COMPARE Study
Nina Strandkjær, Malene Kongsgaard Hansen, Sofie Taageby Nielsen, et al.
The Journal of Clinical Endocrinology & Metabolism (2021) Vol. 107, Iss. 2, pp. 324-335
Open Access | Times Cited: 36
Page 1 - Next Page

Scroll to top